These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Clinical trials: early use of transdermal opioid therapy]. MMW Fortschr Med; 2005 Apr; 147(17):64-5. PubMed ID: 15906440 [No Abstract] [Full Text] [Related]
23. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190 [TBL] [Abstract][Full Text] [Related]
24. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy]. Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357 [No Abstract] [Full Text] [Related]
25. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain. Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811 [TBL] [Abstract][Full Text] [Related]
26. Transdermal fentanyl (Ionsys) for postoperative pain. Med Lett Drugs Ther; 2015 Nov; 57(1481):155-6. PubMed ID: 26529135 [No Abstract] [Full Text] [Related]
27. Transdermal fentanyl for cancer pain. Skorga P; Young CF Clin Nurse Spec; 2014; 28(5):264-5. PubMed ID: 25111404 [No Abstract] [Full Text] [Related]
28. Opioid toxicity as a result of oral/transmucosal administration of transdermal fentanyl patch. Bektas F; Eken C; Sayrac V Eur J Emerg Med; 2009 Dec; 16(6):344-5. PubMed ID: 19904081 [No Abstract] [Full Text] [Related]
29. The transdermal delivery of fentanyl. Lane ME Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814 [TBL] [Abstract][Full Text] [Related]
30. FentaNYL Patch Not Adhering Properly During Use. Shastay A Home Healthc Now; 2017; 35(7):398-399. PubMed ID: 28650373 [No Abstract] [Full Text] [Related]
31. Extent of variability in fentanyl plasma levels during steady-state transdermal delivery in older nursing home residents. Rigler SK; Wiggins S; Mahnken J; Reed GA J Am Geriatr Soc; 2012 Oct; 60(10):1986-8. PubMed ID: 23057458 [No Abstract] [Full Text] [Related]
32. [Effective pain therapy with good tolerability. New opioid administration form by transdermal patch]. MMW Fortschr Med; 2005 Nov; 147(46):66-7. PubMed ID: 16358643 [No Abstract] [Full Text] [Related]
34. How should we use transdermal fentanyl (TF) for pain management in palliative care patients? Fainsinger RL; Bruera E J Palliat Care; 1996; 12(1):48-53. PubMed ID: 8857249 [No Abstract] [Full Text] [Related]
36. Withdrawal symptoms from transdermal fentanyl (TDF) after an allogeneic peripheral blood stem cell transplant (PBSCT). Tsutsumi Y; Kanamori H; Tanaka J; Asaka M; Imamura M; Masauzi N Pain Med; 2006; 7(2):164-5. PubMed ID: 16634729 [TBL] [Abstract][Full Text] [Related]
37. In brief: heat and transdermal fentanyl. Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852 [TBL] [Abstract][Full Text] [Related]
38. The role of transdermal fentanyl patches in the effective management of cancer pain. Gibbs M Int J Palliat Nurs; 2009 Jul; 15(7):354-9. PubMed ID: 19648851 [TBL] [Abstract][Full Text] [Related]
39. A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report. Leppert W Am J Hosp Palliat Care; 2014 Feb; 31(1):101-4. PubMed ID: 23349342 [TBL] [Abstract][Full Text] [Related]